Validation of Iodine-131-meta-iodobenzylguanidine cardiac scintigraphy in Parkinsonism: A preliminary study-Reference-Cited by-同舟云学术

Validation of Iodine-131-meta-iodobenzylguanidine cardiac scintigraphy in Parkinsonism: A preliminary study

Published:2018-05 Issue: Volume:50 Page:69-73
ISSN:1353-8020
Container-title:Parkinsonism & Related Disorders
language:en
Short-container-title:Parkinsonism & Related Disorders

Author:

Xu Dan,Zhu Wenjia,Huo Li,Zhu Shikun,Li Fang,Wang Han^ORCID

Publisher

Elsevier BV

Subject

Neurology (clinical),Geriatrics and Gerontology,Neurology

Reference28 articles.

1. (123)I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in alpha-synucleinopathies;Orimo;Ageing Res. Rev.,2016

2. Clinical implications of cardiac-MIBG SPECT in the differentiation of parkinsonian syndromes;Shin;J. Clin. Neurol.,2006

3. Decreased myocardial accumulation of 123I-meta-iodobenzyl guanidine in Parkinson's disease;Yoshita;Nucl. Med. Commun.,1998

4. Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson's disease and dementia with Lewy bodies;Kashihara;J. Nucl. Med.,2006

5. Combined use of dopamine transporter imaging (DAT-SPECT) and 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy for diagnosing Parkinson's disease;Yoshii;J. Neurol. Sci.,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Nuclear Medicine in the Evaluation of Cardiomyopathies;Journal of The Indian Academy of Echocardiography & Cardiovascular Imaging;2024-05

2. Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson’s Disease: A Comprehensive Review;Brain Sciences;2023-10-18

3. 123I-MIBG Cardiac Scintigraphy and Heart/Mediastinum Ratio in Neurodegenerative Disorders: Is Delayed Scan Really Necessary?;Current Radiopharmaceuticals;2022-12

4. Parkinson’s disease in China: a forty-year growing track of bedside work;Translational Neurodegeneration;2019-07-31